Pure Global AI
NCT06228755Enrolling by invitation

MAGIC Study: More Access to Group Integrative Care

Scaling-Up Integrative Pain Management in Federally-Qualified Health Centers
University of North Carolina, Chapel HillClinicalTrials.govbehavioral
Study focus
Disease/Condition
Chronic Pain
Drug/Device/Intervention
Integrative Medicine Group Visit
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of North Carolina, Chapel Hill
Location
Chapel Hill, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 26, 2024
End date
Sep 01, 2026
Enrollment
70 participants
Primary outcome

Reach: Total Patients Reached,Reach: Race of Patients Reached,Reach: Ethnicity of Patients Reached,Reach: Gender of Patients Reached,Reach: Age of Patients Reached,Adoption,Acceptability: Patients,Acceptability: Clinic Personnel,Cost: Patient Perspective,Cost: Clinic Perspective,Fidelity,Maintenance: 6 months,Maintenance: 12 months

Summary

Chronic pain impacts about 20% of US Adults. Though non-pharmacologic, integrative pain
 management therapies are now considered first-line treatment by clinical guidelines, these
 therapies are still rarely covered by health insurance and therefore inaccessible to
 lower-income individuals. The Integrative Medical Group Visit (IMGV) program was developed to
 offer low-income, diverse patients with chronic pain an introduction to integrative pain
 management approaches, through a model that is covered by health insurance under existing
 billing codes. An initial pragmatic randomized control trial found that IMGV led to
 significant improvement in mental health related quality of life and lower use of high-cost
 care. However, there has been little research investigating the implementation of IMGV, and
 none in Federally-Qualified Health Centers (FQHCs), where the program was initially designed
 to be implemented. In this study, the investigators test strategies to implement IMGV in
 FQHCs, including training and coaching clinic staff, and measure the effectiveness of the
 IMGV on health outcomes for patients with chronic pain.

ICD-10 classifications
Other chronic painChronic intractable painPain, not elsewhere classifiedPain, unspecifiedPain associated with micturition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06228755
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06228755 through Pure Global AI's free database. This phase not specified trial is sponsored by University of North Carolina, Chapel Hill and is currently Enrolling by invitation. The study focuses on Chronic Pain. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.